A Single Dose,Single Centre,Double Blind,Crossover Study Comparing the Pharmacokinetic Profiles of Wockhardt's Insulin Human Injection, Soluble (Recombinant DNA Origin) for Injection and Actrapid in Type 1 Diabetics.
Phase of Trial: Phase I
Latest Information Update: 26 Dec 2012
At a glance
- Drugs Insulin (Primary)
- Indications Type 1 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Wockhardt
- 20 May 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 01 Oct 2008 New trial record.